John-Joseph Borg
Impact in
- Toxicology top 2%
- Pharmacovigilance and Adverse Drug Reactions
Papers in
-
- Pharmaceutical Economics and Policy 9
- Health Systems, Economic Evaluations, Quality of Life 3
-
- Pharmaceutical studies and practices 6
- Co-authors
- Robert Nisticò (3 shared papers)M Pirozyński (3 shared papers)Anthony Serracino‐Inglott (16 shared papers)Daniela Melchiorri (2 shared papers)František Dráfi (1 shared paper)Sara Merlo (1 shared paper)Tomas Salmonson (3 shared papers)Patricia Vella Bonanno (2 shared papers)
- Journals
- Expert Opinion on Drug Safety (3 papers)Drug Safety (2 papers)Therapeutic Advances in Drug Safety (1 paper)Pharmacological Research (1 paper)Journal of Pharmacy & Pharmaceutical Sciences (1 paper)
- Partner nations
- MaltaItalyUnited Kingdom
In The Last Decade
John-Joseph Borg
23 papers receiving 352 citations
Peers
Comparison fields: 5 of 81
- Toxicology 93
- Biological Psychiatry 19
- Geriatrics and Gerontology 11
- Physiology 74
- Neurology 23
Countries citing papers authored by John-Joseph Borg
This map shows the geographic impact of John-Joseph Borg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John-Joseph Borg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John-Joseph Borg more than expected).
Fields of papers citing papers by John-Joseph Borg
This network shows the impact of papers produced by John-Joseph Borg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John-Joseph Borg. The network helps show where John-Joseph Borg may publish in the future.
Co-authors
The 25 scholars most cited alongside John-Joseph Borg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 77 | |
| 2 | 2021 | 50 | |
| 3 | 2013 | 45 | |
| 4 | 2023 | 39 | |
| 5 | 2015 | 25 | |
| 6 | 2020 | 23 | |
| 7 | 2020 | 20 | |
| 8 | 2009 | 13 | |
| 9 | 2017 | 13 | |
| 10 | 2023 | 9 | |
| 11 | 2015 | 9 | |
| 12 | 2013 | 8 | |
| 13 | 2021 | 7 | |
| 14 | 2014 | 6 | |
| 15 | 2017 | 4 | |
| 16 | 2012 | 4 | |
| 17 | 2022 | 4 | |
| 18 | 2016 | 4 | |
| 19 | 2021 | 3 | |
| 20 | 2022 | 3 |
About John-Joseph Borg
John-Joseph Borg is a scholar working on Economics and Econometrics, Pediatrics, Perinatology and Child Health, Toxicology, Physiology and Immunology, having authored 27 papers that have together received 370 indexed citations. Recurring topics across this work include Pharmaceutical Economics and Policy (9 papers), Pharmacovigilance and Adverse Drug Reactions (7 papers), Pharmaceutical studies and practices (6 papers), Biosimilars and Bioanalytical Methods (4 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers), Alzheimer's disease research and treatments (2 papers), Pharmaceutical industry and healthcare (2 papers) and Biomedical Ethics and Regulation (2 papers). The work is most often cited by research in Toxicology (93 citations), Biological Psychiatry (19 citations), Geriatrics and Gerontology (11 citations), Physiology (74 citations) and Neurology (23 citations). John-Joseph Borg has collaborated with scholars based in Malta, Italy and United Kingdom. Frequent co-authors include Robert Nisticò, M Pirozyński, Anthony Serracino‐Inglott, Daniela Melchiorri, František Dráfi, Sara Merlo, Tomas Salmonson, Patricia Vella Bonanno, Dimitrios Kouvelas and Jānis Ancāns. Their work appears in journals such as Expert Opinion on Drug Safety, Drug Safety, Therapeutic Advances in Drug Safety, Pharmacological Research and Journal of Pharmacy & Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.